UBS raised the firm’s price target on RXO Inc. (RXO) to $15 from $14 and keeps a Neutral rating on the shares.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RXO:
- RXO, Inc.: Hold Rating Maintained Amid Stable Outlook and Modest Growth Expectations
- RXO, Inc.: Balancing Profitability Amid Market Challenges with a Hold Rating
- RXO, Inc. Reports Strong Q2 Performance Amid Market Challenges
- RXO, Inc. Hold Rating: Strong LTL and Last Mile Performance Amid TL Challenges and Uncertain Outlook
- RXO Reports Q2 2025 Financial Results with Revenue Growth